Giovanni Leo

EBAMed (External Beam Ablation Medical Devices) is developing an Ultrasound Imaging Solution to enable non-invasive treatment of Cardiac Arrhythmias. The device (CardioKit) offers the following functionalities: target position verification before treatment (to aid in patient setup), Cardiac Motion Monitoring during treatment, Respiratory Gating and Cardiac Gating.

MedLumics is a medical device company with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve the quality of life. Our work is focused on one of the most successful light-based diagnostic techniques, Optical Coherence Tomography, which is currently seeing rapid expansion and growth. Our disruptive technological advantages allow us to offer unique medical solutions and to develop the clinical applications of this imaging modality. MedLumics, Enlightening Healthcare

CV Lab is the first incubator fully focused on cardiovascular innovation in Europe: it selects the most promising ideas and turns them into spin-offs that can be funded by international venture capital. We take the most promising ideas through patenting, prototyping and proof-of-concept, until we are ready to spin-off a new company and seek venture capital funding. We make the most of a network of entrepreneurs and experts with strong expertise in the biomedical sector. We work with the best industry specialists. We are a lean structure very close to researchers and to clinical needs. We are at ease in situations where enterprise risk is higher. We are open to all ideas, but we prefer early projects. We choose the most promising in terms of market potential, clinical need, innovative content and scientific evidence. We prioritize the most structured proposals, aiming to achieve proof-of-concept within 18-24 months and to become standard-of-care within 4 to 8 years.

Health is the level of functional or metabolic efficiency of a living organism. In humans it is the ability of individuals or communities to adapt and self-manage when facing physical, mental or social challenges.

Medyria is a Swiss medtech company that engineers technologies for endovascular catheter navigation and sensing. Medyria objective is to make catheter based procedures faster, safer and more effective. Medyria is based In Technopark, Winterthur., Switzerland

Based in Geneva, Efficient Frontier Investing was founded in 2018 by two former investment managers with the aim of providing niche and lucrative investment opportunities to their clients. EFI specialises in both private and public investment vehicles; from venture capital portfolios of Swiss-based startups companies in technology and life sciences, and Israeli high-tech ventures, to highly concentrated thematic equity portfolios. EFI believes that specific investments and portfolio returns are set by the markets and, as such, cannot be managed. However, the risks associated with such investments and portfolios, once understood, can be attenuated. Our expertise is best applied to managing such risks, which starts by analysing and understanding the inherent risks of the components of the portfolio. We strive to reduce implicit risks while maintaining expected market returns and, in so doing, deliver risk/returns above the Markowitz Efficient Frontier. We have partnered with Cardea Capital SA, a boutique investment firm with offices in Geneva, Barcelona and London, providing specialist merchant banking and investment advisory services; complementing EFI's risk management skills with highly specialised advice and distribution services.

EBAMed (External Beam Ablation Medical Devices) is developing an Ultrasound Imaging Solution to enable non-invasive treatment of Cardiac Arrhythmias. The device (CardioKit) offers the following functionalities: target position verification before treatment (to aid in patient setup), Cardiac Motion Monitoring during treatment, Respiratory Gating and Cardiac Gating.

MedLumics is a medical device company with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve the quality of life. Our work is focused on one of the most successful light-based diagnostic techniques, Optical Coherence Tomography, which is currently seeing rapid expansion and growth. Our disruptive technological advantages allow us to offer unique medical solutions and to develop the clinical applications of this imaging modality. MedLumics, Enlightening Healthcare

CV Lab is the first incubator fully focused on cardiovascular innovation in Europe: it selects the most promising ideas and turns them into spin-offs that can be funded by international venture capital. We take the most promising ideas through patenting, prototyping and proof-of-concept, until we are ready to spin-off a new company and seek venture capital funding. We make the most of a network of entrepreneurs and experts with strong expertise in the biomedical sector. We work with the best industry specialists. We are a lean structure very close to researchers and to clinical needs. We are at ease in situations where enterprise risk is higher. We are open to all ideas, but we prefer early projects. We choose the most promising in terms of market potential, clinical need, innovative content and scientific evidence. We prioritize the most structured proposals, aiming to achieve proof-of-concept within 18-24 months and to become standard-of-care within 4 to 8 years.